For the Inventor, By the Inventor

Enter inventor name

Foster City, CA, United States of America

Yibin Zeng

USPTO Granted Patents = 66 (Patent Applications = 29)

CIPO Patents = 15 (Patent Applications = 23)

EPO Patents = 22 (Patent Applications = 36)

Average Co-Inventor Count = 7.3

ph-index = 13

Forward Citations = 519(Granted Patents)

Forward Citations (Not Self Cited) = 313(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Mateo, CA (US) (2009 - 2022)
Foster City, CA (US) (2012 - 2024)

Company Filing History:

Chemocentryx, Inc.

2 out of 832,891

Other

patents

Years Active: 2009-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

CXCR7 Inhibitors

PD-L1 Diseases

C5aR Antagonists

CCR2 Modulators

Inflammatory Bowel Disease

Deuterated Compounds

Fused Ring Compounds

Heteroaryl Sulfonamides

Aza-Aryl Compounds

Combination Therapy

Immunomodulators

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497383 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2025-12-16),

2. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors (2025-10-21),

3. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2025-07-29),

4. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors (2025-04-08),

5. 12054484 - Substituted tetrahydropyrans as CCR2 modulators (2024-08-06),

6. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies (2024-01-30),

7. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2024-01-09),

8. 11834452 - CXCR7 antagonists (2023-12-05),

9. 11807609 - Deuterated compounds as immunomodulators (2023-11-07),

10. 11773091 - 6-5 fused rings as C5a inhibitors (2023-10-03),

11. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2023-08-01),

12. 11608336 - Prodrugs of fused-bicyclic C5aR antagonists (2023-03-21),

13. 11603356 - Amorphous form of a complement component C5a receptor (2023-03-14),

14. 11485737 - Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors (2022-11-01),

15. 11479553 - 5-5 fused rings as C5a inhibitors (2022-10-25),

Title: Inventor Yibin Zeng: Pioneering Innovations in Foster City

Introduction: Yibin Zeng is a visionary inventor based in Foster City, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Zeng holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse expertise and innovative mindset.

Career Highlights: With a career spanning over two decades, Zeng has worked with leading tech companies and research institutions, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout his career, Zeng has collaborated with top scientists, engineers, and researchers globally, fostering a culture of creativity and excellence in all his projects.

Conclusion: Yibin Zeng's relentless pursuit of innovation and his passion for creating solutions to complex challenges make him a true pioneer in the world of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…